Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportGU

Initial Experience of Lung Metastases Response to 225Ac-PSMA-617 Therapy in Metastatic Prostate Adenocarcinoma

Letjie Maserumule, Kgomotso Mokoala, Frank Bruchertseifer, Mariza Vorster, Janet Reed, Ismaheel Lawal, Alfred Morgenstern and Mike Sathekge
Journal of Nuclear Medicine August 2022, 63 (supplement 2) 2550;
Letjie Maserumule
1Steve Biko Academic Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kgomotso Mokoala
2Department of Nuclear Medicine, University of Pretoria & Steve Biko Academic Hospital, Private Bag X169, Pretoria, 0001, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frank Bruchertseifer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mariza Vorster
3UKZN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Janet Reed
4University of Pretoria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ismaheel Lawal
2Department of Nuclear Medicine, University of Pretoria & Steve Biko Academic Hospital, Private Bag X169, Pretoria, 0001, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alfred Morgenstern
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mike Sathekge
2Department of Nuclear Medicine, University of Pretoria & Steve Biko Academic Hospital, Private Bag X169, Pretoria, 0001, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Article Information

vol. 63 no. supplement 2 2550

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online August 8, 2022.

Copyright & Usage 
© 2022

Author Information

  1. Letjie Maserumule1,
  2. Kgomotso Mokoala2,
  3. Frank Bruchertseifer,
  4. Mariza Vorster3,
  5. Janet Reed4,
  6. Ismaheel Lawal2,
  7. Alfred Morgenstern and
  8. Mike Sathekge2
  1. 1Steve Biko Academic Hospital
  2. 2Department of Nuclear Medicine, University of Pretoria & Steve Biko Academic Hospital, Private Bag X169, Pretoria, 0001, South Africa
  3. 3UKZN
  4. 4University of Pretoria

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: August 2022 to April 2025

AbstractFullPdf
Aug 20221800
Sep 20221100
Oct 20221800
Nov 20222800
Dec 20223000
Jan 20232400
Feb 20235000
Mar 20231800
Apr 20231500
May 20232600
Jun 2023600
Jul 20231700
Aug 2023400
Sep 2023700
Oct 2023800
Nov 20231400
Dec 20231900
Jan 2024700
Feb 2024500
Mar 2024500
Apr 20244300
May 20241800
Jun 20243000
Jul 202410900
Aug 202410800
Sep 20243400
Oct 20241200
Nov 2024900
Dec 20241600
Jan 2025900
Feb 20251500
Mar 20253600
Apr 20252500
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 63, Issue supplement 2
August 1, 2022
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Initial Experience of Lung Metastases Response to 225Ac-PSMA-617 Therapy in Metastatic Prostate Adenocarcinoma
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Initial Experience of Lung Metastases Response to 225Ac-PSMA-617 Therapy in Metastatic Prostate Adenocarcinoma
Letjie Maserumule, Kgomotso Mokoala, Frank Bruchertseifer, Mariza Vorster, Janet Reed, Ismaheel Lawal, Alfred Morgenstern, Mike Sathekge
Journal of Nuclear Medicine Aug 2022, 63 (supplement 2) 2550;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Initial Experience of Lung Metastases Response to 225Ac-PSMA-617 Therapy in Metastatic Prostate Adenocarcinoma
Letjie Maserumule, Kgomotso Mokoala, Frank Bruchertseifer, Mariza Vorster, Janet Reed, Ismaheel Lawal, Alfred Morgenstern, Mike Sathekge
Journal of Nuclear Medicine Aug 2022, 63 (supplement 2) 2550;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Can primary PET/CT staging using [68Ga]Ga-RM2 and [18F]Choline predict recurrence in prostate cancer?
  • Initial outcome of phase I study of Lu-177 Ludotadipep treatment in metastatic castration-resistant prostate cancer patients
  • [68Ga]-PSMA-11 can clarify equivocal lesions on conventional imaging and change management decisions among men with previously treated prostate cancer
Show more GU

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire